Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F96D1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,809
Award facts
- Contract value 100% obligated
- $10,809.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,809.06 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectors on December 30, 2025, with completion targeted for December 31, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The pharmaceutical distributor will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania.
This award supports the Defense Health Agency and broader military healthcare operations through AmerisourceBergen's established role as a critical pharmaceutical vendor for federal medical procurement. Dupixent is a specialty biologic medication used for treating atopic dermatitis, eosinophilic esophagitis, and asthma, reflecting the company's portfolio of delivering specialized therapeutic medications across multiple disease areas. The underlying SPE2DX vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply medications, vaccines, and medical supplies to military healthcare programs worldwide, with DLA planning future regional pharmaceutical prime vendor contracts potentially involving multiple contractors.
Quick answers
Who was awarded contract SPE2DR26F96D1?
SPE2DR26F96D1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26F96D1 worth?
The government has obligated $10,809 on SPE2DR26F96D1.
Is contract SPE2DR26F96D1 an order under another contract?
Yes. SPE2DR26F96D1 is a delivery order under SPE2DR25D3505, an indefinite delivery contract.
Was contract SPE2DR26F96D1 competed?
The extent of competition for SPE2DR26F96D1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award